Kohli Prashant
SEC insider (Form 3/4/5 filer). CIK 0001946739. Chief Executive Officer at Grace Therapeutics, Inc. (GRCE). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 9, 2026. Located in PRINCETON, NJ.
Companies Kohli Prashant has filed insider reports for
- Grace Therapeutics, Inc. (GRCE): Director, Officer, Chief Executive Officer
Kohli Prashant
CIK: 0001946739
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GRCE
Grace Therapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 9, 2026GRCE
Grace Therapeutics, Inc.
PurchaseDirect100K shares at avg. $2.14$214K - Aug 28, 2026GRCE
Grace Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
267.2K shares- - Apr 14, 2025GRCE
Grace Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
225.4K shares-
1-3 of 3 transactions